Cell Biosciences, a Palo Alto, Calif.-based provider of nanoproteomic analysis systems to life science researchers, has acquired Protein Forest, a Lexington, Mass.-based provider of sample preparation technology for proteomic analysis and biomarker discovery. No financial terms were disclosed. Cell Biosciences has raised around $60 million in VC funding from firms like The Wellcome Trust, Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group. Protein Forest had raised around $27 million from Boston Millennia Partners, Flybridge Capital Partners, Novo AS, PureTech Ventures and S.R. One Ltd.
2 min read · 08 December 2009
Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has raised $20 million in new Series B funding from Chicago Growth Partners. This brings the round total to $71 million, with other investors including Clarus Ventures, Domain Associates,Scale Venture Partners, Thomas, McNerney & Partners, Oxford Finance Corp. and Abingworth Management.
3 min read · 08 December 2009
The Michigan Pre-Seed Capital Fund has funded four new companies with a total of $924,000. The companies are: Mandy & Pandy (Chinese language learning for kids), Algal Scientific (nutrient removal for municipal and industrial wastewater), Axenic Dental (disposable high-speed dental drills) and RealBio Technology (3D cell culture tool).
2 min read · 07 December 2009
Enerkem Technologies Inc., a Montreal-based provider of synthetic gass and other alternative fuels, has been selected by the U.S. Department of Energy to receive $50 million for the construction and operation of its waste-to-biofuels facility to be located in Pontotoc, Mississippi. Enerkem has raised VC funding from Rho Ventures, Braemar Energy Ventures and BDR Capital.
3 min read · 07 December 2009
1 min read · 07 December 2009
Braemar Energy Ventures has promoted Scott DePasquale to partner. He joined the firm this past March as a principal and executive-in-residence, after having served as senior VP of GE Energy Financial Services.
3 min read · 07 December 2009
WellAware Systems, a Charlottesville, Va.-based maker of wellness monitoring solutions for senior care providers, has raised $7.5 million in new VC funding from Valhalla Partners and .406 Ventures.
4 min read · 07 December 2009
Celgene Corp. (Nasdaq: CELG) has agreed to acquire Gloucester Pharmaceuticals, a Cambridge, Mass.-based developer of oncology drugs. The deal is valued at up to $640 million, including a $340 million up-front cash payment and up to $300 million in earn-outs. Gloucester Pharma had raised over $130 million in VC funding, from firms like Apple Tree Partners, Novo AS, ProQuest Investments, Prospect Venture Partners and Rho Ventures.
4 min read · 07 December 2009
3 min read · 07 December 2009
Vijay Aggarwal has joined The Channel Group and its BioMed Transition Partners affiliate as a partner. He previously was president and CEO of Aureon Laboratories Inc.
2 min read · 07 December 2009
